1,050
Views
6
CrossRef citations to date
0
Altmetric
Laboratory Study

Effect of 5/6 Nephrectomized Rat Serum on Epithelial-to-Mesenchymal Transition In Vitro

, , , , , , & show all
Pages 600-608 | Received 27 Feb 2011, Accepted 28 Apr 2011, Published online: 10 Jun 2011

REFERENCES

  • Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: Final common pathways to end-stage renal failure. Intern Med. 2004;43(1):9–17.
  • Zeisberg M, Kaluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med. 2004;82(3):175–181.
  • Venkov CD, Link AJ, Jennings JL, A proximal activator of transcription in epithelial-mesenchymal transition. J Clin Invest. 2007;117(2):482–491.
  • Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol. 2001;159(4):1465–1475.
  • Lan HY. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens. 2003;12(1):25–29.
  • Fan JM, Huang XR, Ng YY, Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis. 2001;37(4):820–831.
  • Strutz F, Zeisberg M, Ziyadeh FN, Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int. 2002;61(5):1714–1728.
  • Okada H, Danoff TM, Kalluri R, Neilson EG. Early role of FSP1 in epithelial-mesenchymal transformation. Am J Physiol. 1997;273(4):563–574.
  • Ha H, Lee HB. Reactive oxygen species and matrix remodeling in diabetic kidney. J Am Soc Nephrol. 2003;14(8):246–249.
  • Guarino M, Tosoni A, Nebuloni M. Direct contribution of epithelium to organ fibrosis: Epithelial-mesenchymal transition. Hum Pathol. 2009;40(10):1365–1376.
  • Li HY, Hou FF, Zhang X, Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. J Am Soc Nephrol. 2007;18(2):528–538.
  • Kumagai H, Katoh S, Hirosawa K, Kimura M, Hishida A, Ikegaya N. Renal tubulointerstitial injury in weaning rats with hyperhomocysteinemia. Kidney Int. 2002;62(4):1219–1228.
  • Remuzzi G, Perico N, Macia M, Ruggenenti P. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int. 2005;68(99):57–65.
  • Kliem V, Johnson RJ, Alpers CE, Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int. 1996;49(3):666–678.
  • Yan-chun S, Xiao Y, Qiong-xia C. Renal pathological changes in rat with 5/6 nephrectomy. Shanghai Lab Animal Sci. 2005;25(1):21–25 (Chinese).
  • Floege J, Hackmann B, Kliem V, Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: A podocyte disease. Kidney Int. 1997;51(1):230–243.
  • Copeland JW, Beaumont BW, Merrilees MJ, Pilmore HL. Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: Effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone. Transplantation. 2007;83(6):809–814.
  • Feng JX, Hou FF, Liang M, Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model. Kidney Int. 2007;71(9):901–911.
  • Aros C, Remuzzi G. The renin-angiotensin system in progression, remission and regression of chronic nephropathies. J Hypertens. 2002;20(3):43–45.
  • Yook JI, Li XY, Ota I, Fearon ER, Weiss SJ. Wnt-dependent regulation of the E-cadherin repressor snail. J Biol Chem. 2005;280(12):11740–11748.
  • Perez-Moreno M, Jamora C, Fuchs E. Sticky business: Orchestrating cellular signals at adherens junctions. Cell. 2003;112(4):535–548.
  • Shirakihara T, Saitoh M, Miyazono K. Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol Biol Cell. 2007;18(9):3533–3544.
  • Spaderna S, Schmalhofer O, Wahlbuhl M, The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res. 2008;68(2):537–544.
  • Aigner K, Dampier B, Descovich L, The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene. 2007;26(49):6979–6988.
  • Remacle JE, Kraft H, Lerchner W, New mode of DNA binding of multi-zinc finger transcription factors: DeltaEF1 family members bind with two hands to two target sites. EMBO J. 1999;18(18):5073–5084.
  • Comijn J, Berx G, Vermassen P, The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001;7(6):1267–1278.
  • Perez-Moreno M, Fuchs E. Catenins: Keeping cells from getting their signals crossed. Dev Cell. 2006;11(5):601–612.
  • Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7(2):131–142.
  • Longo KA, Kennell JA, Ochocinska MJ, Ross SE, Wright WS, MacDougald OA. Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J Biol Chem. 2002;277(41):38239–38244.
  • Shao J, Jung C, Liu C, Sheng H. Prostaglandin E2 stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. J Biol Chem. 2005;280(28):26565–26572.
  • Schmalhofer O, Brabletz S, Brabletz T. E-Cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 2009;28(1–2):151–166.